Dynavax Technologies | Aset Lancar



Current Assets Perubahan Tanggal
AbbVie USD 27.68B 2.09B 2025-03
Adma Biologics USD 331.41M 13.22M 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 28.94B 2.8B 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Dynavax Technologies USD 815.97M 32.97M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Merck USD 35.5B 3.28B 2025-03
Neurocrine Biosciences USD 1.75B 111M 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
TG Therapeutics USD 566.36M 7.71M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12


Dynavax Technologies Aset Lancar - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.